Additionally, agents that inhibited hepatic fat synthesis and stimulate the oxidation of skeletal muscle and adipose tissue (such as adipose and anti-obesity agents) could reduce ectopic lipid accumulation, improve insulin sensitivity, and ultimately prevent or delay the onset of diabetes (16, 17). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.